Accelerate Your Success
Schedule Your Consultation Today
Stealth BioTherapeutics is a biopharmaceutical company, developing therapies to treat mitochondrial dysfunction. When Stealth first came to Sagefrog, they were struggling to find patients for their clinical trials. They found that many patients who could have enrolled in their trials, and doctors who could have spread the word to their patients, were not aware of Stealth or its therapies.
Sagefrog began by overhauling the Stealth website and content to make them patient-focused and patient-friendly. The new website includes a new clinical development chart similar to those of most biopharma companies, yet designed to stand out aesthetically and underscore Stealth’s unique process. Our creative team also revamped all the company’s brand materials and imagery to make them visually cohesive and compelling.
In the year since the new brand and website launched, total new user visits to the website increased by 60% and visits from other websites (referrals) increased by 80%. With plans to become a public company traded on NASDAQ, Sagefrog ensured all web design complied with the regulatory requirements for publicly-traded companies. In early 2019, Stealth raised a $78M IPO in their stock market debut.
“Sagefrog revamped our website and marketing materials, getting us ready to take the next step that we had set our sights on: becoming publicly-traded. Our website before was too technical and full of jargon. We’re glad we had the outside eye of an agency to teach us how to shift our focus, as well as how to build brand awareness through direct mail. We’re very happy we went with Sagefrog and excited for what this marketing plan will bring in the future.”